Chemicals - Specialty
Build Your Comparison
Side-by-side financial analysisStock Comparison
CMT vs LIN vs EMN vs HUN
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Chemicals - Specialty
Chemicals
CMT vs LIN vs EMN vs HUN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty | Chemicals |
| Market Cap | $227M | $242.62B | $8.60B | $2.74B |
| Revenue (TTM) | $271M | $34.66B | $8.64B | $5.69B |
| Net Income (TTM) | $10M | $7.13B | $399M | $-324M |
| Gross Margin | 17.6% | 46.0% | 19.8% | 12.9% |
| Operating Margin | 4.4% | 28.8% | 9.4% | -1.0% |
| Forward P/E | 23.0x | 29.3x | 11.8x | — |
| Total Debt | $33M | $26.99B | $5.08B | $2.73B |
| Cash & Equiv. | $38M | $5.06B | $566M | $429M |
CMT vs LIN vs EMN vs HUN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Core Molding Techno… (CMT) | 100 | 598.1 | +498.1% |
| Linde plc (LIN) | 100 | 246.8 | +146.8% |
| Eastman Chemical Co… (EMN) | 100 | 108.0 | +8.0% |
| Huntsman Corporation (HUN) | 100 | 87.6 | -12.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMT vs LIN vs EMN vs HUN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMT is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.49, Low D/E 20.8%, current ratio 3.02x
- +47.7% vs EMN's -0.5%
LIN carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 34 yrs, beta 0.20, yield 1.1%
- Rev growth 3.0%, EPS growth 7.1%, 3Y rev CAGR 0.6%
- 402.9% 10Y total return vs CMT's 88.8%
- PEG 1.15 vs CMT's 4.08
EMN is the clearest fit if your priority is defensive.
- Beta 1.24, yield 4.4%, current ratio 1.37x
- Better valuation composite
HUN lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.0% revenue growth vs CMT's -9.5% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.6% margin vs HUN's -5.7% | |
| Stability / Safety | Beta 0.20 vs HUN's 1.77, lower leverage | |
| Dividends | 1.1% yield, 34-year raise streak, vs HUN's 5.4%, (1 stock pays no dividend) | |
| Momentum (1Y) | +47.7% vs EMN's -0.5% | |
| Efficiency (ROA) | 8.3% ROA vs HUN's -4.6%, ROIC 11.3% vs -0.6% |
CMT vs LIN vs EMN vs HUN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CMT vs LIN vs EMN vs HUN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LIN leads in 4 of 6 categories
HUN leads 1 • CMT leads 0 • EMN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LIN leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LIN is the larger business by revenue, generating $34.7B annually — 127.9x CMT's $271M. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to HUN's -5.7%. On growth, LIN holds the edge at +8.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $271M | $34.7B | $8.6B | $5.7B |
| EBITDAEarnings before interest/tax | $21M | $12.1B | $1.2B | $160M |
| Net IncomeAfter-tax profit | $10M | $7.1B | $399M | -$324M |
| Free Cash FlowCash after capex | -$15M | $5.1B | $498M | $135M |
| Gross MarginGross profit ÷ Revenue | +17.6% | +46.0% | +19.8% | +12.9% |
| Operating MarginEBIT ÷ Revenue | +4.4% | +28.8% | +9.4% | -1.0% |
| Net MarginNet income ÷ Revenue | +3.5% | +20.6% | +4.6% | -5.7% |
| FCF MarginFCF ÷ Revenue | -5.7% | +14.7% | +5.8% | +2.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.7% | +8.2% | -4.9% | +0.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -72.2% | +13.4% | -40.8% | -3.3% |
Valuation Metrics
HUN leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 18.3x trailing earnings, EMN trades at a 49% valuation discount to LIN's 35.9x P/E. Adjusting for growth (PEG ratio), LIN offers better value at 1.41x vs EMN's 5.71x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $227M | $242.6B | $8.6B | $2.7B |
| Enterprise ValueMkt cap + debt − cash | $222M | $264.6B | $13.1B | $5.0B |
| Trailing P/EPrice ÷ TTM EPS | 19.10x | 35.89x | 18.35x | -9.90x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.03x | 29.25x | 11.79x | — |
| PEG RatioP/E ÷ EPS growth rate | 3.38x | 1.41x | 5.71x | — |
| EV / EBITDAEnterprise value multiple | 8.34x | 20.83x | 9.08x | 20.34x |
| Price / SalesMarket cap ÷ Revenue | 0.83x | 7.14x | 0.98x | 0.48x |
| Price / BookPrice ÷ Book value/share | 1.35x | 6.17x | 1.44x | 0.92x |
| Price / FCFMarket cap ÷ FCF | 118.29x | 47.68x | 20.29x | 23.61x |
Profitability & Efficiency
LIN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-8 for HUN. CMT carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to HUN's 0.92x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs HUN's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.2% | +17.8% | +6.7% | -8.1% |
| ROA (TTM)Return on assets | +4.2% | +8.3% | +2.6% | -4.6% |
| ROICReturn on invested capital | +7.6% | +11.3% | +6.7% | -0.6% |
| ROCEReturn on capital employed | +7.8% | +13.0% | +7.5% | -0.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.21x | 0.68x | 0.84x | 0.92x |
| Net DebtTotal debt minus cash | -$5M | $21.9B | $4.5B | $2.3B |
| Cash & Equiv.Liquid assets | $38M | $5.1B | $566M | $429M |
| Total DebtShort + long-term debt | $33M | $27.0B | $5.1B | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | 144.87x | 34.52x | 2.22x | -1.08x |
Total Returns (Dividends Reinvested)
LIN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LIN five years ago would be worth $18,914 today (with dividends reinvested), compared to $7,456 for EMN. Over the past 12 months, CMT leads with a +47.7% total return vs EMN's -0.5%. The 3-year compound annual growth rate (CAGR) favors LIN at 14.3% vs HUN's -9.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +26.6% | +22.8% | +18.2% | +55.3% |
| 1-Year ReturnPast 12 months | +47.7% | +12.6% | -0.5% | +39.2% |
| 3-Year ReturnCumulative with dividends | +28.5% | +49.4% | +5.4% | -26.7% |
| 5-Year ReturnCumulative with dividends | +82.5% | +89.1% | -25.4% | -24.0% |
| 10-Year ReturnCumulative with dividends | +88.8% | +402.9% | +41.6% | +51.1% |
| CAGR (3Y)Annualised 3-year return | +8.7% | +14.3% | +1.8% | -9.8% |
Risk & Volatility
LIN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LIN is the less volatile stock with a 0.20 beta — it tends to amplify market swings less than HUN's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 99.6% from its 52-week high vs CMT's 85.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.49x | 0.20x | 1.24x | 1.77x |
| 52-Week HighHighest price in past year | $28.69 | $525.82 | $83.47 | $15.93 |
| 52-Week LowLowest price in past year | $16.12 | $387.78 | $56.11 | $7.30 |
| % of 52W HighCurrent price vs 52-week peak | +85.9% | +99.6% | +90.1% | +98.8% |
| RSI (14)Momentum oscillator 0–100 | 55.7 | 56.9 | 49.7 | 58.0 |
| Avg Volume (50D)Average daily shares traded | 32K | 2.0M | 1.1M | 4.4M |
Analyst Outlook
Evenly matched — LIN and HUN each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CMT as "Buy", LIN as "Buy", EMN as "Buy", HUN as "Hold". Consensus price targets imply 7.4% upside for LIN (target: $562) vs -18.7% for HUN (target: $13). For income investors, HUN offers the higher dividend yield at 5.37% vs LIN's 1.15%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $24.00 | $562.14 | $79.89 | $12.80 |
| # AnalystsCovering analysts | 2 | 28 | 35 | 33 |
| Dividend YieldAnnual dividend ÷ price | — | +1.1% | +4.4% | +5.4% |
| Dividend StreakConsecutive years of raises | 0 | 34 | 16 | 0 |
| Dividend / ShareAnnual DPS | — | $6.00 | $3.30 | $0.85 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +1.9% | +1.2% | +0.1% |
LIN leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HUN leads in 1 (Valuation Metrics). 1 tied.
CMT vs LIN vs EMN vs HUN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CMT or LIN or EMN or HUN a better buy right now?
For growth investors, Linde plc (LIN) is the stronger pick with 3.
0% revenue growth year-over-year, versus -9. 5% for Core Molding Technologies, Inc. (CMT). Eastman Chemical Company (EMN) offers the better valuation at 18. 3x trailing P/E (11. 8x forward), making it the more compelling value choice. Analysts rate Core Molding Technologies, Inc. (CMT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMT or LIN or EMN or HUN?
On trailing P/E, Eastman Chemical Company (EMN) is the cheapest at 18.
3x versus Linde plc at 35. 9x. On forward P/E, Eastman Chemical Company is actually cheaper at 11. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Linde plc wins at 1. 15x versus Core Molding Technologies, Inc. 's 4. 08x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CMT or LIN or EMN or HUN?
Over the past 5 years, Linde plc (LIN) delivered a total return of +89.
1%, compared to -25. 4% for Eastman Chemical Company (EMN). Over 10 years, the gap is even starker: LIN returned +402. 9% versus EMN's +41. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMT or LIN or EMN or HUN?
By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.
20β versus Huntsman Corporation's 1. 77β — meaning HUN is approximately 795% more volatile than LIN relative to the S&P 500. On balance sheet safety, Core Molding Technologies, Inc. (CMT) carries a lower debt/equity ratio of 21% versus 92% for Huntsman Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CMT or LIN or EMN or HUN?
By revenue growth (latest reported year), Linde plc (LIN) is pulling ahead at 3.
0% versus -9. 5% for Core Molding Technologies, Inc. (CMT). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -46. 5% for Eastman Chemical Company. Over a 3-year CAGR, LIN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMT or LIN or EMN or HUN?
Linde plc (LIN) is the more profitable company, earning 20.
3% net margin versus -4. 8% for Huntsman Corporation — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -0. 7% for HUN. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMT or LIN or EMN or HUN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Linde plc (LIN) is the more undervalued stock at a PEG of 1. 15x versus Core Molding Technologies, Inc. 's 4. 08x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Eastman Chemical Company (EMN) trades at 11. 8x forward P/E versus 29. 3x for Linde plc — 17. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for LIN: 7. 4% to $562. 14.
08Which pays a better dividend — CMT or LIN or EMN or HUN?
In this comparison, HUN (5.
4% yield), EMN (4. 4% yield), LIN (1. 1% yield) pay a dividend. CMT does not pay a meaningful dividend and should not be held primarily for income.
09Is CMT or LIN or EMN or HUN better for a retirement portfolio?
For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
20), 1. 1% yield, +402. 9% 10Y return). Huntsman Corporation (HUN) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +402. 9%, HUN: +51. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMT and LIN and EMN and HUN?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CMT is a small-cap quality compounder stock; LIN is a large-cap quality compounder stock; EMN is a small-cap income-oriented stock; HUN is a small-cap income-oriented stock. LIN, EMN, HUN pay a dividend while CMT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.